Literature DB >> 6472343

Warfarin. From bedside to bench.

S Wessler, S N Gitel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6472343     DOI： 10.1056/NEJM198409063111007

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

Review 1.  Why is warfarin underutilized in patients with atrial fibrillation?

Authors:  Greg C Flaker; John Schutz
Journal:  J Interv Card Electrophysiol       Date:  2004       Impact factor: 1.900

Review 2.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing.

Authors:  R H White; R Hong; A P Venook; M M Daschbach; W Murray; D R Mungall; R W Coleman
Journal:  J Gen Intern Med       Date:  1987 May-Jun       Impact factor: 5.128

4.  Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.

Authors:  S Vigano D'Angelo; P C Comp; C T Esmon; A D'Angelo
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

5.  Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal.

Authors:  R A Asherson; J K Chan; E N Harris; A E Gharavi; G R Hughes
Journal:  Ann Rheum Dis       Date:  1985-12       Impact factor: 19.103

Review 6.  Therapeutic target values in oral anticoagulation--justification of Dutch policy and a warning against the so-called moderate-intensity regimens.

Authors:  E A Loeliger
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

Review 7.  Anticoagulation therapy in children.

Authors:  Milind D Ronghe; Christina Halsey; Nicholas J Goulden
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

8.  Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.

Authors:  A Zivelin; L V Rao; S I Rapaport
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

Review 9.  Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

10.  Protean manifestations of pylethrombosis. A review of thirty-four patients.

Authors:  C L Witte; M L Brewer; M H Witte; G B Pond
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.